As precision medicine demands more complex study designs, static lab manuals and traditional methods for biospecimen management introduce serious risks. This white paper sheds light on the lab manual’s current role in sample management, the inherent pitfalls of traditional approaches, and the ways in which sponsors can leverage technological innovations to standardize research site practices and optimize compliance across all of their trials.